Skip to main content
. 2011 Mar 24;66(6):1287–1294. doi: 10.1093/jac/dkr104

Table 1.

Effect of selected teicoplanin aglycone analogues on the replication of HCV replicons

Huh Mono
Huh 9-13
LCTA EC50 CC50 EC50 CC50
563 5.1 ± 0.7 >60 15 ± 2.6 >60
877 14 ± 2.6 >60 10 ± 8.9 >60
901 29 ± 1.0 >60 54 ± 12 >60
914 4.8 ± 2.1 >60 17 ± 2.2 >60
949 6.9 ± 2.1 >60 3.9 ± 0.9 >60
VX-950 1.0 ± 0.3 >33 0.4 ± 0.1 24 ± 4

Data are expressed in μM and are means ± SD for three or four independent experiments.

The NS3 protease inhibitor (VX-950) is given as a reference HCV inhibitor.